Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Mettler Toledo (MTD)

NYSE Health Care Life Sciences Tools & Services S&P 500
$1,722.15
+43.07 (+2.57%)
Close of Nov 06, 2026 · end-of-day data
Source: Mettler Toledo's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$2.51B$2.73B$2.94B$3.01B$3.09B$3.72B$3.92B$3.79B$3.87B$4.03B
Cost of revenue$767.75M$833.79M————————
Gross profit$1.44B$1.58B$1.68B$1.74B$1.80B$2.17B$2.31B$2.24B$2.33B$2.39B
Research & development$119.20M$128.31M$141.07M$143.95M$140.10M$169.77M$177.12M$185.28M$189.36M$199.37M
Selling, general & admin$745.36M$794.86M$812.80M$819.18M$820.22M$943.98M$938.46M$904.11M$936.30M$998.31M
Interest expense$28.03M$32.78M$34.51M$37.41M$38.62M$43.24M$55.39M$77.37M$74.63M$68.52M
Pre-tax income$504.19M$574.22M$651.86M$681.39M$748.74M$949.36M$1.07B$973.73M$1.04B$1.05B
Income tax$119.82M$198.25M$139.25M$120.28M$146.00M$180.38M$198.09M$184.95M$174.08M$179.72M
Net income$384.37M$375.97M$512.61M$561.11M$602.74M$768.99M$872.50M$788.78M$863.14M$869.19M
EPS (basic)$14.49$14.62$20.33$22.84$25.24$33.25$38.79$36.10$40.67$42.17
EPS (diluted)$14.22$14.24$19.88$22.47$24.91$32.78$38.41$35.90$40.48$42.05
Diluted shares27.02M26.39M25.78M24.97M24.20M23.46M22.72M21.97M21.32M20.67M
Gross margin57.3%57.8%57.4%57.9%58.4%58.4%58.9%59.2%60.1%59.4%
Net margin15.3%13.8%17.5%18.6%19.5%20.7%22.3%20.8%22.3%21.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$158.67M$148.69M$178.11M$207.78M$94.25M$98.56M$95.97M$69.81M$59.36M$66.89M
Receivables$454.99M$528.62M$535.53M$566.26M$593.81M$647.34M$709.32M$663.89M$687.11M$778.24M
Inventory$222.05M$255.39M$268.82M$274.29M$297.61M$414.54M$441.69M$385.87M$342.27M$387.23M
Total current assets$896.78M$1.01B$1.05B$1.11B$1.06B$1.27B$1.38B$1.23B$1.19B$1.36B
Goodwill$476.38M$539.84M$534.78M$535.98M$550.27M$648.62M$660.17M$670.11M$668.91M$739.23M
Total assets$2.17B$2.55B$2.62B$2.79B$2.81B$3.33B$3.49B$3.36B$3.24B$3.71B
Total current liabilities$587.51M$689.67M$734.43M$754.51M$840.33M$1.15B$1.15B$1.18B$1.17B$1.20B
Short-term debt$18.97M$19.68M$49.67M$55.87M$50.32M$101.13M$106.05M$192.22M$182.62M$63.93M
Long-term debt$875.06M$960.17M$985.02M$1.24B$1.28B$1.58B$1.91B$1.89B$1.83B$2.09B
Total debt$894.03M$979.85M$1.03B$1.29B$1.33B$1.68B$2.01B$2.08B$2.01B$2.15B
Total liabilities$1.73B$2.00B$2.03B$2.37B$2.53B$3.16B$3.47B$3.51B$3.37B$3.74B
Shareholders' equity$434.94M$547.28M$590.06M$420.78M$282.68M$171.42M$24.79M-$149.94M-$126.89M-$23.64M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$460.76M$516.33M$565.00M$603.45M$724.70M$908.83M$859.07M$965.87M$968.35M$955.77M
Capital expenditures$123.96M$127.43M$142.73M$97.34M$92.49M$107.58M$121.24M$105.32M$103.90M$107.12M
Free cash flow$336.80M$388.90M$422.28M$506.11M$632.21M$801.25M$737.83M$860.55M$864.45M$848.65M
Investing cash flow-$231.46M-$217.34M-$138.94M-$99.08M-$100.36M-$314.11M-$139.40M-$131.69M-$119.46M-$193.87M
Financing cash flow-$163.60M-$319.53M-$388.02M-$477.37M-$743.91M-$590.55M-$716.04M-$859.59M-$855.98M-$755.17M
Share buybacks$499.99M$400.00M$475.00M$775.00M$775.00M$1000.00M$1.10B$900.00M$850.00M$800.00M
Stock-based compensation$15.31M$16.58M$17.58M$18.29M$18.69M$19.59M$19.66M$17.93M$19.98M$22.51M
Depreciation & amortization$32.74M$33.46M$37.17M$38.99M$42.04M$44.98M$46.78M$48.95M$50.35M$51.14M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.